2021 Q4 Form 10-K Financial Statement

#000162828022014386 Filed on May 13, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $39.78M $43.56M $115.0M
YoY Change 278.46% 210.52% 157.07%
% of Gross Profit
Research & Development $80.43M $79.76M $174.9M
YoY Change 1367.68% 2165.82% 766.62%
% of Gross Profit
Depreciation & Amortization $3.890M $2.221M $8.158M
YoY Change 727.66% 133.79% 131.96%
% of Gross Profit
Operating Expenses $120.2M $185.7M $354.1M
YoY Change 958.05% 445.36%
Operating Profit -$185.7M -$354.1M
YoY Change 958.05% 445.36%
Interest Expense -$4.529M -$1.893M -$46.84M
YoY Change 1013.68% -4852.7% -36.46%
% of Operating Profit
Other Income/Expense, Net $32.74M $1.117M -$5.668M
YoY Change -283.03% -149.42% 3.9%
Pretax Income -$84.06M -$303.9M -$516.3M
YoY Change 3286.73% 811.56% 251.0%
Income Tax $237.0K $0.00 $240.0K
% Of Pretax Income
Net Earnings -$84.30M -$303.9M -$516.5M
YoY Change 3295.87% 811.56% 251.16%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$278.9K -$1.005M -$1.709M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $505.1M $666.1M $505.1M
YoY Change 91835.02% 106007.98% 44836.92%
Cash & Equivalents $505.1M $666.1M
Short-Term Investments
Other Short-Term Assets $13.41M $13.25M $102.2M
YoY Change 116.29% 9730.79% 669.61%
Inventory
Prepaid Expenses $11.12M $11.49M
Receivables $0.00 $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $607.3M $754.6M $607.3M
YoY Change 4105.67% 98870.57% 4105.67%
LONG-TERM ASSETS
Property, Plant & Equipment $293.1M $261.6M $293.1M
YoY Change -0.27% -0.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.040M $7.287M $7.040M
YoY Change -12.11% 2428900.0% -12.11%
Total Long-Term Assets $300.2M $268.8M $300.2M
YoY Change -0.59% 16.98% -0.59%
TOTAL ASSETS
Total Short-Term Assets $607.3M $754.6M $607.3M
Total Long-Term Assets $300.2M $268.8M $300.2M
Total Assets $907.4M $1.023B $907.4M
YoY Change 186.82% 343.87% 186.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.77M $36.18M $37.77M
YoY Change -56.38% -56.38%
Accrued Expenses $90.51M $47.34M $58.13M
YoY Change 72.79% 92240.55% -59.21%
Deferred Revenue $4.354M $4.229M
YoY Change 23.59%
Short-Term Debt $13.66M $13.46M $13.66M
YoY Change -95.44%
Long-Term Debt Due $134.9M $107.0M $134.9M
YoY Change -27.66%
Total Short-Term Liabilities $293.8M $238.2M $293.8M
YoY Change -65.4% 464506.98% -65.4%
LONG-TERM LIABILITIES
Long-Term Debt $42.25M $135.6M $42.25M
YoY Change -7.48%
Other Long-Term Liabilities $3.720M $4.129M $3.720M
YoY Change 272.0% 272.0%
Total Long-Term Liabilities $3.720M $4.129M $45.97M
YoY Change 272.0% -1.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $293.8M $238.2M $293.8M
Total Long-Term Liabilities $3.720M $4.129M $45.97M
Total Liabilities $339.8M $377.9M $339.8M
YoY Change -62.07% 737054.28% -62.07%
SHAREHOLDERS EQUITY
Retained Earnings -$2.908B -$2.823B
YoY Change 21.6%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $567.7M $645.5M $567.7M
YoY Change
Total Liabilities & Shareholders Equity $907.4M $1.023B $907.4M
YoY Change 186.82% 343.87% 186.82%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021
OPERATING ACTIVITIES
Net Income -$84.30M -$303.9M -$516.5M
YoY Change 3295.87% 811.56% 251.16%
Depreciation, Depletion And Amortization $3.890M $2.221M $8.158M
YoY Change 727.66% 133.79% 131.96%
Cash From Operating Activities -$101.9M -$185.6M -$339.8M
YoY Change 129974.05% 81933.07% 725.37%
INVESTING ACTIVITIES
Capital Expenditures -$58.42M -$35.88M $95.68M
YoY Change -292185.0% -7422.04% 15662.93%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$58.42M -$35.88M -$95.68M
YoY Change -84.39% -3296.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $206.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -426.0K 855.5M $966.6M
YoY Change 270.98% 2524.34%
NET CHANGE
Cash From Operating Activities -101.9M -185.6M -$339.8M
Cash From Investing Activities -58.42M -35.88M -$95.68M
Cash From Financing Activities -426.0K 855.5M $966.6M
Net Change In Cash -160.7M 634.0M $528.7M
YoY Change 205095.97% 106801.99% -34720.17%
FREE CASH FLOW
Cash From Operating Activities -$101.9M -$185.6M -$339.8M
Capital Expenditures -$58.42M -$35.88M $95.68M
Free Cash Flow -$43.47M -$149.7M -$435.4M
YoY Change 44108.28% 20800.15% 942.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001805521
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-39395
CY2021 dei Entity Registrant Name
EntityRegistrantName
Faraday Future Intelligent Electric Inc.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-4720320
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
18455 S. Figueroa Street
CY2021 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Gardena
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90248
CY2021 dei City Area Code
CityAreaCode
310
CY2021 dei Local Phone Number
LocalPhoneNumber
415-4807
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
362800000 USD
CY2021 dei Auditor Firm
AuditorFirmId
238
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
6200000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
607257000 USD
CY2021 dei Auditor Location
AuditorLocation
Los Angeles, California
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
505091000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1124000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
25386000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
703000 USD
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
63370000 USD
CY2020Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
6412000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
13410000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
14439000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
293135000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
293933000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7040000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8010000 USD
CY2021Q4 us-gaap Assets
Assets
907432000 USD
CY2020Q4 ffie Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
82260000 USD
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
8263000 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
36030000 USD
CY2020Q4 us-gaap Assets
Assets
316382000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
37773000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
86601000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
90512000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52382000 USD
CY2021Q4 ffie Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
11231000 USD
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
13655000 USD
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
332355000 USD
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
132372000 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
149199000 USD
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 USD
CY2020Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
110224000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
293806000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
849051000 USD
CY2021Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
7570000 USD
CY2020Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
36501000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3720000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1000000 USD
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
34682000 USD
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
9168000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
339778000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
895720000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3482226000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1817760000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6945000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5974000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2907644000 USD
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17118000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2391139000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
567654000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-579338000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
907432000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
316382000 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
174935000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20186000 USD
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3672000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
97905000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41071000 USD
CY2021 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
64191000 USD
CY2020 us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
10000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
354149000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
64939000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-354149000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-64939000 USD
CY2021 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-22700000 USD
CY2020 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-5076000 USD
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
30181000 USD
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
32173000 USD
CY2021 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
16663000 USD
CY2020 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
41546000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5668000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5455000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-86904000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2107000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-516265000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-147082000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
240000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-516505000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-147085000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-516505000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-147085000 USD
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-971000 USD
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2690000 USD
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-517476000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-149775000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-439662000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9505000 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
115000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
490000 USD
CY2020 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
11000 USD
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2690000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-147085000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-579338000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-579338000 USD
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2863000 USD
CY2021 ffie Conversion Of Related Party Notes Payable To Class A Common Stock
ConversionOfRelatedPartyNotesPayableToClassACommonStock
294796000 USD
CY2021 ffie Conversion Of Notes Payable To Class A Common Stock
ConversionOfNotesPayableToClassACommonStock
98375000 USD
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
170114000 USD
CY2021 ffie Stock Issued During Period Value Conversion Of Assumed Securities
StockIssuedDuringPeriodValueConversionOfAssumedSecurities
790000 USD
CY2021 ffie Stock Issued During Period Value Conversion Of Liabilities Related To Reverse Recapitalization
StockIssuedDuringPeriodValueConversionOfLiabilitiesRelatedToReverseRecapitalization
311798000 USD
CY2021 ffie Adjustments To Additional Paid In Capital Conversion Of Liabilities Into Commitment To Issue Shares
AdjustmentsToAdditionalPaidInCapitalConversionOfLiabilitiesIntoCommitmentToIssueShares
25877000 USD
CY2021 ffie Stock Exchanged During Period Value
StockExchangedDuringPeriodValue
0 USD
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
692405000 USD
CY2021 ffie Adjustments To Additional Paid In Capital Stock Options Issued Upon Settlement Of Lawsuit
AdjustmentsToAdditionalPaidInCapitalStockOptionsIssuedUponSettlementOfLawsuit
8459000 USD
CY2021 ffie Adjustments To Additional Paid In Capital Stock Options Issued Upon Settlement Of Accrued Rent
AdjustmentsToAdditionalPaidInCapitalStockOptionsIssuedUponSettlementOfAccruedRent
951000 USD
CY2021 ffie Stock Issued During Period Value Vesting Of Restricted Stock Award For Employee Bonus
StockIssuedDuringPeriodValueVestingOfRestrictedStockAwardForEmployeeBonus
18617000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11345000 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10587000 USD
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
105000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
17596000 USD
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-971000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-516505000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
567654000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-516505000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-147085000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8158000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3517000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
11345000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
9505000 USD
CY2021 ffie Vesting Of Restricted Stock Awards For Employee Bonus
VestingOfRestrictedStockAwardsForEmployeeBonus
18617000 USD
CY2020 ffie Vesting Of Restricted Stock Awards For Employee Bonus
VestingOfRestrictedStockAwardsForEmployeeBonus
0 USD
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-64191000 USD
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-10000 USD
CY2021 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-22700000 USD
CY2020 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-5076000 USD
CY2021 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 USD
CY2020 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-206000 USD
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
845000 USD
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4108000 USD
CY2021 ffie Gain Loss From Write Off Of Accounts Payable
GainLossFromWriteOffOfAccountsPayable
7005000 USD
CY2020 ffie Gain Loss From Write Off Of Accounts Payable
GainLossFromWriteOffOfAccountsPayable
0 USD
CY2021 us-gaap Paid In Kind Interest
PaidInKindInterest
41014000 USD
CY2020 us-gaap Paid In Kind Interest
PaidInKindInterest
66020000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-86904000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2107000 USD
CY2021 ffie Gain On Forgiveness Of Vendor Payables In Trust
GainOnForgivenessOfVendorPayablesInTrust
1731000 USD
CY2020 ffie Gain On Forgiveness Of Vendor Payables In Trust
GainOnForgivenessOfVendorPayablesInTrust
0 USD
CY2021 ffie Reserve For Unrecoverable Value Added Taxes
ReserveForUnrecoverableValueAddedTaxes
6404000 USD
CY2020 ffie Reserve For Unrecoverable Value Added Taxes
ReserveForUnrecoverableValueAddedTaxes
0 USD
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-842000 USD
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
CY2021 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
48503000 USD
CY2020 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
0 USD
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
21717000 USD
CY2020 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
3347000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-36625000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11500000 USD
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
31824000 USD
CY2020 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
11606000 USD
CY2021 ffie Transfer Of Vendor Payable In Trust To Accounts Payable Transfer Of Accounts Payable To Vendor Payable In Trust
TransferOfVendorPayableInTrustToAccountsPayableTransferOfAccountsPayableToVendorPayableInTrust
-1167000 USD
CY2020 ffie Transfer Of Vendor Payable In Trust To Accounts Payable Transfer Of Accounts Payable To Vendor Payable In Trust
TransferOfVendorPayableInTrustToAccountsPayableTransferOfAccountsPayableToVendorPayableInTrust
174000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-339765000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41165000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
95681000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
607000 USD
CY2021 ffie Proceeds From Payments On Notes Receivable
ProceedsFromPaymentsOnNotesReceivable
0 USD
CY2020 ffie Proceeds From Payments On Notes Receivable
ProceedsFromPaymentsOnNotesReceivable
3600000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-95681000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2993000 USD
CY2021 ffie Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
229583000 USD
CY2020 ffie Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
0 USD
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
761400000 USD
CY2020 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
CY2021 ffie Payments Of Reverse Recapitalization Transaction Costs Acquisition
PaymentsOfReverseRecapitalizationTransactionCostsAcquisition
23148000 USD
CY2020 ffie Payments Of Reverse Recapitalization Transaction Costs Acquisition
PaymentsOfReverseRecapitalizationTransactionCostsAcquisition
0 USD
CY2021 ffie Payments Of Reverse Recapitalization Transaction Costs Pipe Financing
PaymentsOfReverseRecapitalizationTransactionCostsPIPEFinancing
61130000 USD
CY2020 ffie Payments Of Reverse Recapitalization Transaction Costs Pipe Financing
PaymentsOfReverseRecapitalizationTransactionCostsPIPEFinancing
0 USD
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
200000 USD
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
10556000 USD
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
172031000 USD
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
40595000 USD
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
38217000 USD
CY2020 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
3589000 USD
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
48210000 USD
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
32000 USD
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
3355000 USD
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4562000 USD
CY2021 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
27722000 USD
CY2020 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
4500000 USD
CY2021 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-1167000 USD
CY2020 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
174000 USD
CY2021 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
3212000 USD
CY2020 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
1926000 USD
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10587000 USD
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
115000 USD
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1071000 USD
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
966569000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36831000 USD
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2473000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-186000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
528650000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1527000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1827000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3354000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
530477000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1827000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1124000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2221000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
703000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1133000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1827000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3354000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
505091000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1124000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
25386000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
703000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
530477000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1827000 USD
CY2021 ffie Conversion Of Related Party Notes Payable And Related Party Accrued Interest To Equity
ConversionOfRelatedPartyNotesPayableAndRelatedPartyAccruedInterestToEquity
294796000 USD
CY2020 ffie Conversion Of Related Party Notes Payable And Related Party Accrued Interest To Equity
ConversionOfRelatedPartyNotesPayableAndRelatedPartyAccruedInterestToEquity
0 USD
CY2021 ffie Conversion Of Notes Payable And Accrued Interest To Equity
ConversionOfNotesPayableAndAccruedInterestToEquity
98375000 USD
CY2020 ffie Conversion Of Notes Payable And Accrued Interest To Equity
ConversionOfNotesPayableAndAccruedInterestToEquity
0 USD
CY2021 ffie Warrants Issued
WarrantsIssued
17596000 USD
CY2020 ffie Warrants Issued
WarrantsIssued
490000 USD
CY2021 ffie Conversion Of Assumed Convertible And Promissory Notes Payable To Class A Common Stock And Private Warrants
ConversionOfAssumedConvertibleAndPromissoryNotesPayableToClassACommonStockAndPrivateWarrants
1080000 USD
CY2020 ffie Conversion Of Assumed Convertible And Promissory Notes Payable To Class A Common Stock And Private Warrants
ConversionOfAssumedConvertibleAndPromissoryNotesPayableToClassACommonStockAndPrivateWarrants
0 USD
CY2021 ffie Additions Of Property And Equipment Included In Accounts Payable And Accrued Expense
AdditionsOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpense
863000 USD
CY2020 ffie Additions Of Property And Equipment Included In Accounts Payable And Accrued Expense
AdditionsOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpense
3817000 USD
CY2021 ffie Conversion Of Customer Deposits To Notes Payable
ConversionOfCustomerDepositsToNotesPayable
0 USD
CY2020 ffie Conversion Of Customer Deposits To Notes Payable
ConversionOfCustomerDepositsToNotesPayable
11635000 USD
CY2021 ffie Settlement Of Notes Payable And Accrued Interest To A Commitment To Issue Class A Common Stock
SettlementOfNotesPayableAndAccruedInterestToACommitmentToIssueClassACommonStock
68541000 USD
CY2020 ffie Settlement Of Notes Payable And Accrued Interest To A Commitment To Issue Class A Common Stock
SettlementOfNotesPayableAndAccruedInterestToACommitmentToIssueClassACommonStock
0 USD
CY2021 ffie Settlement Of Related Party Notes Payable And Related Party Accrued Interest To A Commitment To Issue Class A Common Stock
SettlementOfRelatedPartyNotesPayableAndRelatedPartyAccruedInterestToACommitmentToIssueClassACommonStock
69218000 USD
CY2020 ffie Settlement Of Related Party Notes Payable And Related Party Accrued Interest To A Commitment To Issue Class A Common Stock
SettlementOfRelatedPartyNotesPayableAndRelatedPartyAccruedInterestToACommitmentToIssueClassACommonStock
0 USD
CY2021 ffie Settlement Of Interests In The Vendor Trust Including Future Work To Class A Common Stock
SettlementOfInterestsInTheVendorTrustIncludingFutureWorkToClassACommonStock
96186000 USD
CY2020 ffie Settlement Of Interests In The Vendor Trust Including Future Work To Class A Common Stock
SettlementOfInterestsInTheVendorTrustIncludingFutureWorkToClassACommonStock
0 USD
CY2021 ffie Offsetting Of Deferred Transaction Costs Paid In Prior Periods Against The Proceeds Received In The Business Combination
OffsettingOfDeferredTransactionCostsPaidInPriorPeriodsAgainstTheProceedsReceivedInTheBusinessCombination
7865000 USD
CY2020 ffie Offsetting Of Deferred Transaction Costs Paid In Prior Periods Against The Proceeds Received In The Business Combination
OffsettingOfDeferredTransactionCostsPaidInPriorPeriodsAgainstTheProceedsReceivedInTheBusinessCombination
0 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
6317000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
3137000 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions which affect the reported amounts in the Consolidated Financial Statements.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimates are based on historical experience, where applicable, and other assumptions which management believes are reasonable under the circumstances. On an ongoing basis management evaluates its estimates, including those related to the: (i) realization of tax assets and estimates of tax liabilities; (ii) valuation of equity securities; (iii) recognition and disclosure of contingent liabilities, including litigation reserves; (iv) fair value of related party notes payable and notes payable; (v) estimated useful lives and impairment of long-lived assets; (vi) fair value of options granted to employees and non-employees; and (vii) fair value of warrants. Such estimates often require the selection of appropriate valuation methodologies and financial models </span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and may involve significant judgment in evaluating ranges of assumptions and financial inputs. Actual results may differ from those estimates under different assumptions, financial inputs, or circumstances. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the global economic climate, unpredictable nature and unknown duration of the COVID-19 pandemic, estimates are subject to additional volatility. As of the date the Company’s Consolidated Financial Statements were issued, the Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or to revise the carrying value of its assets or liabilities. However, these estimates and judgments may change as new events occur and additional information is obtained, which may result in changes being recognized in the Company’s Consolidated Financial Statements in future periods. While the Company considered the effects of COVID-19 on its estimates and assumptions, due to the level of uncertainty regarding the economic and operational impacts of COVID-19 on the Company’s business, there may be other judgments and assumptions that the Company has not considered. Such judgments and assumptions could result in a material impact on the Company’s financial statements in future periods. Actual results could differ from those estimates and any such differences may have a material impact on the Company’s Consolidated Financial Statements.</span></div>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Risk</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which subject the Company to concentrations of credit risk, consist primarily of cash, restricted cash, notes receivables, and deposits. Substantially all of the Company’s cash and restricted cash is held at financial institutions located in the United States of America and in the People’s Republic of China. The Company maintains its cash and restricted cash with major financial institutions. At times, cash and restricted cash account balances with any one financial institution may exceed Federal Deposit Insurance Corporation (“FDIC”) insurance limits ($250 per depositor per institution) and China Deposit Insurance Regulations limits (CNY 500 per depositor per institution). Management believes the financial institutions that hold the Company’s cash and restricted cash are financially sound and, accordingly, minimal credit risk exists with respect to cash and restricted cash. Cash and restricted cash held by the Company’s non-U.S. subsidiaries is subject to foreign currency fluctuations against the U.S. Dollar. If, however, the U.S. Dollar is devalued significantly against the Chinese Yuan, the Company’s cost to develop its business in China could exceed original estimates.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has notes receivable of $0 and $40 and deposits of $63,370 and $6,412 as of December 31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company receives certain components from sole suppliers. The inability of a supplier to fulfill the Company’s supply requirements could materially impact future operating results.</span></div>
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
500000 CNY
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 USD
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
40000 USD
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
63370000 USD
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
6412000 USD
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2021 ffie Going Concern Period
GoingConcernPeriod
P1Y
CY2021 ffie Going Concern Period
GoingConcernPeriod
P1Y
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2907644000 USD
CY2021Q3 ffie Proceeds From Reverse Recapitalization Transaction Gross
ProceedsFromReverseRecapitalizationTransactionGross
990983000 USD
CY2021Q3 ffie Proceeds From Reverse Recapitalization Transaction Portion To Pay For Transaction Costs
ProceedsFromReverseRecapitalizationTransactionPortionToPayForTransactionCosts
84278000 USD
CY2021Q3 ffie Proceeds From Reverse Recapitalization Transaction Portion For Settlement Of Certain Liabilities
ProceedsFromReverseRecapitalizationTransactionPortionForSettlementOfCertainLiabilities
139557000 USD
CY2021Q3 ffie Proceeds From Reverse Recapitalization Transaction Remaining Portion For Ongoing Business Operations
ProceedsFromReverseRecapitalizationTransactionRemainingPortionForOngoingBusinessOperations
767148000 USD
CY2021Q3 ffie Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
0.14130
CY2021Q3 ffie Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
229583000 USD
CY2021Q3 ffie Cash Received Through Reverse Recapitalization
CashReceivedThroughReverseRecapitalization
206435000 USD
CY2021Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
206000 USD
CY2021Q3 ffie Conversion Of Stock Conversion Ratio
ConversionOfStockConversionRatio
1
CY2021Q3 ffie Reverse Recapitalization Contingent Consideration Equity Number Of Tranches
ReverseRecapitalizationContingentConsiderationEquityNumberOfTranches
2 tranche
CY2021Q3 ffie Stockholders Equity Contingently Issuable Common Stock
StockholdersEquityContingentlyIssuableCommonStock
293853000 USD
CY2021Q3 ffie Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Acquired From Acquisition
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAcquiredFromAcquisition
2152000 USD
CY2021 ffie Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Acquired From Acquisition
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAcquiredFromAcquisition
642000 USD
CY2021Q3 ffie Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
229583000 USD
CY2021Q4 ffie Gain Loss On Extinguishment Of Debt Excluding Forgiveness Of Vendor Interest
GainLossOnExtinguishmentOfDebtExcludingForgivenessOfVendorInterest
-94727000 USD
CY2021Q3 ffie Vendor Payable
VendorPayable
19791000 USD
CY2021Q3 us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
36000 USD
CY2021Q3 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
225000 USD
CY2021Q3 ffie Noncash Or Part Noncash Acquisition Accrued Expenses And Other Current Liabilities Assumed
NoncashOrPartNoncashAcquisitionAccruedExpensesAndOtherCurrentLiabilitiesAssumed
5108000 USD
CY2021Q3 ffie Noncash Or Part Noncash Acquisition Transaction Costs Assumed
NoncashOrPartNoncashAcquisitionTransactionCostsAssumed
18040000 USD
CY2021Q3 ffie Noncash Or Part Noncash Acquisition Related Party Notes Payable Assumed
NoncashOrPartNoncashAcquisitionRelatedPartyNotesPayableAssumed
1080000 USD
CY2021Q3 ffie Noncash Or Part Noncash Acquisition Warrant Liability Assumed
NoncashOrPartNoncashAcquisitionWarrantLiabilityAssumed
2152000 USD
CY2021Q3 ffie Noncash Or Part Noncash Acquisition Obligation To Issue Registered Shares
NoncashOrPartNoncashAcquisitionObligationToIssueRegisteredShares
32900000 USD
CY2021Q3 ffie Reverse Recapitalization Net
ReverseRecapitalizationNet
170114000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
42193512 shares
CY2021Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
761400000 USD
CY2021Q3 ffie Repayment Of Liabilities For Reverse Recapitalization
RepaymentOfLiabilitiesForReverseRecapitalization
139557000 USD
CY2021Q3 us-gaap Notes Payable
NotesPayable
85202000 USD
CY2021Q3 ffie Notes Payable Accrued Interest
NotesPayableAccruedInterest
7436000 USD
CY2021Q3 us-gaap Convertible Debt
ConvertibleDebt
124671000 USD
CY2021Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
102950000 USD
CY2021Q3 ffie Purchase Orders Payable
PurchaseOrdersPayable
8380000 USD
CY2021Q3 ffie Purchase Orders Payable Accrued Interest
PurchaseOrdersPayableAccruedInterest
13341000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
9592000 USD
CY2021Q3 ffie Stock Converted Reverse Recapitalization
StockConvertedReverseRecapitalization
160637633 shares
CY2021Q3 ffie Stock Issued During Period Shares New Issues From Reverse Recapitalization
StockIssuedDuringPeriodSharesNewIssuesFromReverseRecapitalization
27798411 shares
CY2021Q3 ffie Stock Issued During Period Shares Conversion Of Assumed Securities
StockIssuedDuringPeriodSharesConversionOfAssumedSecurities
80000 shares
CY2021Q3 ffie Total Note Conversion And Share Issuance Pursuant To The Reverse Recapitalization
TotalNoteConversionAndShareIssuancePursuantToTheReverseRecapitalization
188516044 shares
CY2021Q3 ffie Stock Issued During Period Shares Conversion Of Liabilities Related To Reverse Recapitalization
StockIssuedDuringPeriodSharesConversionOfLiabilitiesRelatedToReverseRecapitalization
24464994 shares
CY2021Q3 ffie Stock Issued During Period Shares Reverse Recapitalization
StockIssuedDuringPeriodSharesReverseRecapitalization
244293395 shares
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
76140000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
320433395 shares
CY2021Q3 ffie Reverse Recapitalization Net
ReverseRecapitalizationNet
170114000 USD
CY2021Q3 ffie Temporary Equity Converted Reverse Recapitalization Value
TemporaryEquityConvertedReverseRecapitalizationValue
1815637000 USD
CY2021Q3 ffie Debt Instrument Debt Settlement Amount
DebtInstrumentDebtSettlementAmount
800000 USD
CY2021Q3 ffie Stock Issued During Period Shares Conversion Of Assumed Securities
StockIssuedDuringPeriodSharesConversionOfAssumedSecurities
80000 shares
CY2021Q3 ffie Payments Of Reverse Recapitalization Transaction Costs Gross
PaymentsOfReverseRecapitalizationTransactionCostsGross
125943000 USD
CY2021Q3 ffie Payments Of Reverse Recapitalization Transaction Costs Expensed As Part Of Acquisition
PaymentsOfReverseRecapitalizationTransactionCostsExpensedAsPartOfAcquisition
900000 USD
CY2021Q3 ffie Payments Of Reverse Recapitalization Transaction Costs Equity Issuance Costs
PaymentsOfReverseRecapitalizationTransactionCostsEquityIssuanceCosts
125043000 USD
CY2021Q3 ffie Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
229583000 USD
CY2021Q3 ffie Payments Of Reverse Recapitalization Transaction Costs Excluding Accrued Costs
PaymentsOfReverseRecapitalizationTransactionCostsExcludingAccruedCosts
23148000 USD
CY2021Q3 ffie Cash Acquired Through Reverse Recapitalization Net
CashAcquiredThroughReverseRecapitalizationNet
206435000 USD
CY2021Q3 ffie Reverse Recapitalization Net Exclusive Of Cash And Accrued Transaction Costs
ReverseRecapitalizationNetExclusiveOfCashAndAccruedTransactionCosts
-3421000 USD
CY2021Q3 ffie Noncash Or Part Noncash Acquisition Obligation To Issue Registered Shares
NoncashOrPartNoncashAcquisitionObligationToIssueRegisteredShares
32900000 USD
CY2021Q3 ffie Reverse Recapitalization Net
ReverseRecapitalizationNet
170114000 USD
CY2021Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
761400000 USD
CY2021Q3 ffie Payments Of Reverse Recapitalization Transaction Costs Pipe Financing
PaymentsOfReverseRecapitalizationTransactionCostsPIPEFinancing
61130000 USD
CY2021Q3 ffie Offsetting Of Deferred Transaction Costs Paid In Prior Periods Against The Proceeds Received In The Business Combination
OffsettingOfDeferredTransactionCostsPaidInPriorPeriodsAgainstTheProceedsReceivedInTheBusinessCombination
7865000 USD
CY2021Q3 ffie Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
692405000 USD
CY2021Q3 ffie Payments Of Reverse Recapitalization Transaction Costs Acquisition
PaymentsOfReverseRecapitalizationTransactionCostsAcquisition
23148000 USD
CY2021Q3 ffie Payments Of Reverse Recapitalization Transaction Costs Pipe Financing
PaymentsOfReverseRecapitalizationTransactionCostsPIPEFinancing
61130000 USD
CY2021Q3 ffie Offsetting Of Deferred Transaction Costs Paid In Prior Periods Against The Proceeds Received In The Business Combination
OffsettingOfDeferredTransactionCostsPaidInPriorPeriodsAgainstTheProceedsReceivedInTheBusinessCombination
7865000 USD
CY2021Q3 ffie Noncash Or Part Noncash Acquisition Obligation To Issue Registered Shares
NoncashOrPartNoncashAcquisitionObligationToIssueRegisteredShares
32900000 USD
CY2021Q3 ffie Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
125043000 USD
CY2021Q4 ffie Deposit Assets For Research And Development Prototype Parts And Other
DepositAssetsForResearchAndDevelopmentPrototypePartsAndOther
54990000 USD
CY2020Q4 ffie Deposit Assets For Research And Development Prototype Parts And Other
DepositAssetsForResearchAndDevelopmentPrototypePartsAndOther
6412000 USD
CY2021Q4 ffie Deposit For Future Work
DepositForFutureWork
8380000 USD
CY2020Q4 ffie Deposit For Future Work
DepositForFutureWork
0 USD
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
63370000 USD
CY2020Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
6412000 USD
CY2021Q4 ffie Notes Receivable Current
NotesReceivableCurrent
11119000 USD
CY2020Q4 ffie Notes Receivable Current
NotesReceivableCurrent
762000 USD
CY2021Q4 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
2291000 USD
CY2020Q4 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
3364000 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
40000 USD
CY2021Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
0 USD
CY2020Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
2034000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
13410000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
6200000 USD
CY2021Q4 ffie Received Tooling Machinery And Equipment
ReceivedToolingMachineryAndEquipment
0 USD
CY2020Q4 ffie Received Tooling Machinery And Equipment
ReceivedToolingMachineryAndEquipment
0 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9678000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19067000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
293135000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
293933000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8158000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3517000 USD
CY2021Q4 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
2974000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21752000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
19180000 USD
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
16881000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5025000 USD
CY2021Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2574000 USD
CY2020Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
4396000 USD
CY2021Q4 ffie Tooling Machinery And Equipment Received Not Invoiced
ToolingMachineryAndEquipmentReceivedNotInvoiced
7243000 USD
CY2020Q4 ffie Tooling Machinery And Equipment Received Not Invoiced
ToolingMachineryAndEquipmentReceivedNotInvoiced
509000 USD
CY2021Q4 ffie Engineering Design And Testing Service Received Not Invoiced
EngineeringDesignAndTestingServiceReceivedNotInvoiced
6620000 USD
CY2020Q4 ffie Engineering Design And Testing Service Received Not Invoiced
EngineeringDesignAndTestingServiceReceivedNotInvoiced
0 USD
CY2021Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
4354000 USD
CY2020Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
3523000 USD
CY2021Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
6673000 USD
CY2020Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
5123000 USD
CY2021Q4 ffie Obligation To Issue Registered Shares
ObligationToIssueRegisteredShares
12635000 USD
CY2020Q4 ffie Obligation To Issue Registered Shares
ObligationToIssueRegisteredShares
0 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11780000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14626000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
90512000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52382000 USD
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 USD
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 USD
CY2021Q4 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
8975000 USD
CY2020Q2 us-gaap Proceeds From Loans
ProceedsFromLoans
9168000 USD
CY2020Q2 ffie Deferral Payments Period
DeferralPaymentsPeriod
P2Y
CY2020Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.01
CY2020Q2 ffie Unforgiven Portion Period
UnforgivenPortionPeriod
P6M
CY2019Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
11515000 USD
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
164689000 USD
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 USD
CY2021 ffie Obligations To Purchase Inventory And Other Commitments
ObligationsToPurchaseInventoryAndOtherCommitments
P1Y
CY2021Q4 us-gaap Purchase Obligation
PurchaseObligation
388672000 USD
CY2021 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2665000 USD
CY2020 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2452000 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2384000 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2695000 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2775000 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2859000 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2944000 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
991000 USD
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
14648000 USD
CY2021 ffie Number Of Leases
NumberOfLeases
3 lease
CY2021Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
2574000 USD
CY2021Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
2166000 USD
CY2021Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
1757000 USD
CY2021Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
1792000 USD
CY2021Q4 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
1840000 USD
CY2021Q4 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
1864000 USD
CY2021Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
11993000 USD
CY2021Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
16881000 USD
CY2021Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
6 claim
CY2020Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
6025000 USD
CY2020Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
4 claim
CY2020Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
5025000 USD
CY2020 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
2500000 USD
CY2020 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
2255000 USD
CY2020 ffie Unpaid Vendor Payments
UnpaidVendorPayments
6082000 USD
CY2020 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
6082000 USD
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 ffie Preferred Stock Shares To Be Issued
PreferredStockSharesToBeIssued
0 shares
CY2021Q4 ffie Shares Authorized
SharesAuthorized
835000000 shares
CY2021Q4 us-gaap Shares Issued
SharesIssued
168693323 shares
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3000 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
48017000 USD
CY2021Q4 ffie Shares To Be Issued
SharesToBeIssued
153152718 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 ffie Preferred Stock Shares To Be Issued
PreferredStockSharesToBeIssued
0 shares
CY2020Q4 ffie Shares Authorized
SharesAuthorized
835000000 shares
CY2020Q4 us-gaap Shares Issued
SharesIssued
157100184 shares
CY2020Q4 ffie Shares To Be Issued
SharesToBeIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 ffie Preferred Stock Voting Rights Threshold
PreferredStockVotingRightsThreshold
1 vote
CY2021Q4 ffie Common Stock Voting Rights Number Of Consecutive Trading Days For Qualifying Event
CommonStockVotingRightsNumberOfConsecutiveTradingDaysForQualifyingEvent
20 trading_day
CY2021Q4 ffie Common Stock Voting Rights Weighted Average Equity Market Capitalization Threshold
CommonStockVotingRightsWeightedAverageEquityMarketCapitalizationThreshold
20000000000 USD
CY2021Q3 ffie Repayment Of Liabilities For Reverse Recapitalization
RepaymentOfLiabilitiesForReverseRecapitalization
139557000 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
11456000 USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
49894000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000 USD
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
237000 USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
240000 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
9956000 USD
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
107867000 USD
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
2044000 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
13500000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
240000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-408520000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-79605000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-107745000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-67480000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-516265000 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.038
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.001
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.013
CY2021 ffie Effective Income Tax Rate Reconciliation Fair Value Debt Adjustments Percent
EffectiveIncomeTaxRateReconciliationFairValueDebtAdjustmentsPercent
-0.045
CY2020 ffie Effective Income Tax Rate Reconciliation Fair Value Debt Adjustments Percent
EffectiveIncomeTaxRateReconciliationFairValueDebtAdjustmentsPercent
-0.006
CY2021 ffie Effective Income Tax Rate Reconciliation Disallowed Interest Rate Percent
EffectiveIncomeTaxRateReconciliationDisallowedInterestRatePercent
-0.004
CY2020 ffie Effective Income Tax Rate Reconciliation Disallowed Interest Rate Percent
EffectiveIncomeTaxRateReconciliationDisallowedInterestRatePercent
-0.027
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.002
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.067
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.031
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.004
CY2021 ffie Effective Income Tax Rate Reconciliation Uncertain Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationUncertainTaxBenefitPercent
-0.004
CY2020 ffie Effective Income Tax Rate Reconciliation Uncertain Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationUncertainTaxBenefitPercent
0
CY2021 ffie Effective Income Tax Rate Reconciliation Expiration Of Tax Attributes Percent
EffectiveIncomeTaxRateReconciliationExpirationOfTaxAttributesPercent
-0.017
CY2020Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
3670000 USD
CY2021Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
3420000 USD
CY2020 ffie Effective Income Tax Rate Reconciliation Expiration Of Tax Attributes Percent
EffectiveIncomeTaxRateReconciliationExpirationOfTaxAttributesPercent
-0.010
CY2021 ffie Effective Income Tax Rate Reconciliation State Tax Rate Change On Deferred Taxes Percent
EffectiveIncomeTaxRateReconciliationStateTaxRateChangeOnDeferredTaxesPercent
0.064
CY2020 ffie Effective Income Tax Rate Reconciliation State Tax Rate Change On Deferred Taxes Percent
EffectiveIncomeTaxRateReconciliationStateTaxRateChangeOnDeferredTaxesPercent
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.208
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.091
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
225339000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
123633000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
4240000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
7921000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
16258000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
7564000 USD
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
3061000 USD
CY2021Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
5018000 USD
CY2020Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
2407000 USD
CY2021Q4 ffie Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
12176000 USD
CY2020Q4 ffie Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
187000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
428000 USD
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1714000 USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
296000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
268352000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
148980000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
256413000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
148546000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
11939000 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
434000 USD
CY2021Q4 ffie Deferred Tax Liabilities Property Plant And Equipment Net
DeferredTaxLiabilitiesPropertyPlantAndEquipmentNet
573000 USD
CY2020Q4 ffie Deferred Tax Liabilities Property Plant And Equipment Net
DeferredTaxLiabilitiesPropertyPlantAndEquipmentNet
-454000 USD
CY2021Q4 ffie Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
11366000 USD
CY2020Q4 ffie Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
888000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
11939000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
434000 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
256413000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
148546000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
638270000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
80528000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2666000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2598000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2331000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
68000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4997000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2666000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
148546000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
135046000 USD
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
107867000 USD
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
13500000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
256413000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
148546000 USD
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
78695235 shares
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37165739 shares

Files In Submission

Name View Source Status
0001628280-22-014386-index-headers.html Edgar Link pending
0001628280-22-014386-index.html Edgar Link pending
0001628280-22-014386.txt Edgar Link pending
0001628280-22-014386-xbrl.zip Edgar Link pending
ex1035firstamendmenttoempl.htm Edgar Link pending
ex211subsidiariesoftheregi.htm Edgar Link pending
ex311q42021-ceo.htm Edgar Link pending
ex312q42021-cfo.htm Edgar Link pending
ex321q42021-ceo.htm Edgar Link pending
ex322q42021-cfo.htm Edgar Link pending
ex32bylaws.htm Edgar Link pending
ex44-descriptionofsecuriti.htm Edgar Link pending
ffie-20211231.htm Edgar Link pending
ffie-20211231.xsd Edgar Link pending
ffie-20211231_cal.xml Edgar Link unprocessable
ffie-20211231_def.xml Edgar Link unprocessable
ffie-20211231_g1.jpg Edgar Link pending
ffie-20211231_g2.jpg Edgar Link pending
ffie-20211231_g3.jpg Edgar Link pending
ffie-20211231_g4.jpg Edgar Link pending
ffie-20211231_g5.jpg Edgar Link pending
ffie-20211231_g6.jpg Edgar Link pending
ffie-20211231_g7.jpg Edgar Link pending
ffie-20211231_g8.jpg Edgar Link pending
ffie-20211231_htm.xml Edgar Link completed
ffie-20211231_lab.xml Edgar Link unprocessable
ffie-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending